Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

12.23
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
3.30
Today|||52-Week Range
14.48
+233.24%
Year-to-Date

Today’s Trading

Previous close12.23
Today’s open12.42
Day’s range12.06 - 12.86
Volume5,593,802
Average volume (3 months)3,250,318
Market cap$1.9B
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)-137.10%
Earnings growth (this year)+28.80%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-4.39%
P/E ratioNM
Price/Sales298.60
Price/Book--

Competitors

 Today’s
change
Today’s
% change
QDELQuidel Corp0.000.00%
--Quidel Corp+0.09+0.27%
----
LNTHLantheus Holdings In...0.000.00%
Data as of 4:00pm ET, 12/15/2017

Financials

Next reporting dateFebruary 8, 2018
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$3.1M
Annual profit (last year)-$153.2M
Net profit margin-4,956.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer-
Designee
Michael Pehl
Chief Financial Officer &
Vice President
Michael R. Garone
Corporate headquarters
Morris Plains, New Jersey

Forecasts